Claremon, David A.,Dillard, Lawrence Wayne,Fan, Yi,Lotesta, Stephen D.,Singh, Suresh B.,Tice, Colin M.,Zhao, Wei,Zhuang, Linghang
申请号：
AU2017212577
公开号：
AU2017212577A1
申请日:
2017.01.27
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
Provided are novel compounds of Formula I: pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful in the treatment of diseases and disorders mediated by RORy. Also provided are pharmaceutical compositions comprising the novel compounds of Formula I and methods for their use in treating one or more inflammatory, metabolic, autoimmune and other diseases or disorders.
